Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 413 participants.

Also called NCT01388361

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 413 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01388361
  • EudraCT 2011-001493-25
Other papers using this trial's data
  • A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON) Diabetes, obesity & metabolism, 2014-07 DOI, PubMed 24443830

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Norway, Serbia, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01388361. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2012-07 (actual). Results posted on 2015-11-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
Acronym
BEGIN™
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
insulin degludec
Intervention (Drug)
insulin aspart
Intervention (Drug)
liraglutide
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01388361
Content hash
1067e75ebf565f506baa758360366cc5b9361c0052f3b8e8a3f6400b54c13f83